Lucille Downing, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: S1595 Scenic Dr, Hillsboro, WI 54634 Phone: 608-487-0630 |
Mrs. Dawn E. Hoshor, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: S4108 State Highway 80, Hillsboro, WI 54634 Phone: 608-489-2935 |
Shawna Marie Hefel, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11998 County Highway H, Hillsboro, WI 54634 Phone: 319-350-6144 |
Mrs. Colette Jean Fitzpatrick, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 518 Water Ave, Hillsboro, WI 54634 Phone: 608-489-3473 |
Paige L Woggon, Registered Nurse - Obstetric, Inpatient Medicare: Medicare Enrolled Practice Location: 400 Water Ave, Hillsboro, WI 54634 Phone: 608-489-8000 |
Ms. Brenda Krupa, RN, MSN, PNP, APNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Water Ave, Hillsboro, WI 54634 Phone: 608-489-8115 Fax: 608-489-8181 |
News Archive
New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings. A team of scientists have successfully mirrored the infection cycle of C. difficile by generating a 'mouse hospital' with conditions mimicking the human environment in which C. difficile is transmitted.
Some mature brain cells can grow new extensions when the amount of three particular proteins on their surface increases, a new study shows.
After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial, report University of California San Diego School of Medicine and University of Michigan researchers.
Akonni Biosystems, a molecular diagnostics (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health (NIH).
› Verified 2 days ago